Patent directory · USPTO A61K / A61P
Patents matching “BOARD OF REGENTS”
2,639 pharma patents match "BOARD OF REGENTS" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,639 pharmaceutical patents matching "BOARD OF REGENTS" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 9618521
Sperm-specific cation channel, Catsper2, and uses therefor
granted -
US 9617511
Tissue-specific differentiation matrices and uses thereof
granted -
US 9616076
Methods for treating viral infections using hydrogen sulfide donors
granted -
US 9611266
Compounds and anti-tumor NQO1 substrates
granted -
US 9611292
Peptide inhibitors of serotonin 5-HT2c receptors:PTEN interaction
granted -
US 9605057
Endotrophin neutralization and use thereof
granted -
US 9603945
Heparosan polymers and methods of making and using same for the enhancement of therapeutics
granted -
US 9603896
Peptide compounds and methods of production and use thereof
granted -
US 9598694
Micro-RNAs involved in macular degeneration
granted -
US 9598697
Recombinant bacterium to decrease tumor growth
granted -
US 9593080
Triazabutadienes as cleavable cross-linkers
granted -
US 9593131
Copper-cysteamine and methods of use
granted -
US 9592238
Anti-ceramide monoclonal antibody 2A2
granted -
US 9585954
Mucosal immunization
granted -
US 9585910
Polymers functionalized with ion-specific recognition elements
granted -
US 9580690
Attenuated recombinant alphaviruses incapable of replicating in mosquitoes and uses thereof
granted -
US 9580472
Anti-microbial peptides and methods of use thereof
granted -
US 9580718
Attenuated live bacteria with increased acid resistance and methods of use thereof
granted -
US 9579370
Compositions and methods for enterohemorrhagic Escherichia coli (EHEC)vaccination
granted -
US 9574191
Selective inhibition of polyglutamine protein expression
granted -
US 9573906
Therapeutic compounds
granted -
US 9572828
Treatment for melanoma
granted -
US 9567393
Antibody based reagent that specifically recognizes toxic oligomeric form of beta-amyloid
granted -
US 9566310
Methods of treating muscular dystrophy
granted